Company Overview
| Stock Name | Ak Medical |
|---|---|
| Stock Code | 01789 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要從事設計、開發、生產及銷售骨關節植入物及相關產品。 |
| Listing Date | 2017-12-20 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市昌平區科技園區白浮泉路10號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.ak-medical.net |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 1.75 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 131,250,000 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|---|
| Analysis Result | Already included in Stock Connect (both, shenzhen, shanghai) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 2.64 |
|---|---|
| First Day Open | HK$ 1.75 |
| First Day Change | 50.86% |
| First Day Volume | 214153000.0 |
| First Day Turnover | 456984000.0 |
Use of Proceeds
| Use of Proceeds | 1、約41.0%將主要用于我們常州設施的建設，并在較少程度上升級我們于北京現有的設施，及為常洲設施及我們于北京現有的設施收購新設備； 2、約21.0%將用作開發及升級我們的3D打印產品及醫工交互平臺； 3、約15.0%將用作其他研發活動； 4、約15.0%將用于撥付能夠補充我們的現有產品組合、技術及業務增長的潛在收購及發展戰略聯盟； 5、約8.0%將用作一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536
Overall Coordinators (1)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536
Joint Bookrunners (1)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536
Joint Lead Managers (2)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 李志疆 |
|---|---|
| Company Secretary | 馬榮堃 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 李志疆及家族成員(46.18%);HHLR Advisors, Ltd.(6.79%);張朝陽(5.27%) |
|---|
